Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 47.24
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The firm involves in the production of granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio serves niche therapy areas like oncology and anesthesiology. The company was founded on June 15, 1989 and is headquartered in Hyderabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/
Data is available to registered users only
Buy
Sell